![]() |
|
|
1 Smith Kline and French Laboratories, Philadelphia, Pennsylvania
Propranolol (1-5 x 10-4 M) was found to shift the hemoglobin-oxygen dissociation curve of human erythrocytes significantly to the right; the mean p50 was increased in various studies by 6 to 8 mm Hg. The dissociation curve was measured in vitro on freshly obtained, washed red blood cells previously incubated for 90 minutes in physiological buffer (pH 7.4, T = 37°C) which contained the test compound. Concomitant with shifting the curve, propranolol also altered the morphology of the red blood cells and reduced the hematocrit. d-Propranolol was more effective than the l-form in shifting the curve and INPEA, MJ 1999 and Kö 592 were ineffective at 5 x 10-4 M, indicating the effect was not beta receptor mediated. Propranolol did not affect the dissociation curve of dialyzed hemoglobin or of erythrocytes obtained from out-dated blood. Biochemically, the drug significantly decreased the erythrocyte content of 2,3-diphosphoglyceric acid and adenosine triphosphate and inhibited glucose utilization by
60%. The onset of propranolol action on cellular morphology and the dissociation curve was essentially instantaneous and peaked within approximately 20 minutes which suggests these effects may be membrane mediated.
This article has been cited by other articles:
![]() |
A. Agostoni, C. Berfasconi, G. C. Gerli, M. Luzzana, and L. Rossi-Bernardi Oxygen Affinity and Electrolyte Distribution of Human Blood: Changes Induced by Propranolol Science, October 19, 1973; 182(4109): 300 - 301. [Abstract] [PDF] |
||||
![]() |
E. G. Brann, D. J. Newman, and F. A. Oski Oxygen Affinity in Red Cells: Inability to Show Membrane-Bound 2,3-Diphosphoglycerate Science, February 9, 1973; 179(4073): 593 - 593. [PDF] |
||||